Which Is The Best Choice? Catalyst Pharmaceutical Partners, Inc. (CPRX), DeVry Education Group Inc (DV) and DURECT Corporation (DRRX)
New York, NY – GDP INSIDER – 04/27/2014.
This article discusses three companies: Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), DeVry Education Group Inc (NYSE:DV) and DURECT Corporation (NASDAQ:DRRX)
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) plummeted 20.99% during trading on Friday as the stock lost $0.98 to finish the day at a closing price of $3.69 on much higher than average trading volume of 13.245 million, compared to its three month average trading volume of 0.951 million. The stock began to drop after its competitor, Jacobus Pharmaceuticals, positive clinical trial results of its experimental drug, 3,4 Dap, on patients with Lambert-Eaton Mysatetic Syndrome. Despite the drastic decline, the US based biopharmaceutical company is trading well above its 52 week low of $1.70. With a one year target estimate of $7.60 and RSI of 33.65, the stock has plenty of upside potential, making it a hold.
DeVry Education Group Inc (NYSE:DV) plunged on Friday with the stock hitting a new one year low of $30.39 when it fell 18.29% or $6.87 to close at $ 30.70 with more than 4.181 million shares changing hands, compared to its three month average trading volume of 0.710 million. The shares of DeVry Education Group Inc started to decline after it reported soft third quarter 2015 financial results in after-hours trading on April 23rd, 2015. The company reported earnings of 70 cents a share for the third quarter, beating analysts’ estimates of 68 cents a share by 2 cents but declined 19.5% yoy. With an RSI of 28.90 and one year price target of $38.22, the stock looks set for a significant upward swing in the near future.
DURECT Corporation (NASDAQ:DRRX) suffered an unexpected loss of $0.46 after hitting a new one year high of $2.65 during the day to close 17.90% at $2.11 with more than 2.122 million shares changing hands compared to its three month average trading volume of 0.722 million. The specialty pharmaceutical company’s drastic decrease in value came despite the fact that the company did not make any significant announcements or release any financial figures. Despite the loss, DURECT Corporation is trading well above its 52 week low of $0.68, making it a hold.
About Ultimate Stock Alerts
UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit www.UltimateStockAlerts.com
Disclosure: UltimateStockAlerts.com is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.